Clinical Trials on Lung Cancer, Non-small Cell in Switzerland
Total 429 results
-
Centre Hospitalier Universitaire VaudoisRecruiting
-
Philogen S.p.A.Active, not recruitingNon-small Cell Lung Cancer (NSCLC)Switzerland
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
NovoCure Ltd.CompletedNSCLC | Non-small Cell Lung CancerSwitzerland
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompletedLung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung CancerSwitzerland
-
Kai-Uwe Schmitt, PhD, MEng, ICIDRecruitingNon-Small Cell Lung Cancer (NSCLC)Switzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingNon-small Cell Lung Cancer (NSCLC) | Stage IVSwitzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedSquamous-cell Non-small Cell Lung CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchRecruitingNSCLC | Non-small Cell Lung CancerSwitzerland
-
CureVacCompletedNon Small Cell Lung CancerSwitzerland, Germany
-
Blueprint Medicines CorporationAnalysis Group, Inc.Enrolling by invitationNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Carcinoma | Neoplasms, Germ Cell and Embryonal | Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Bronchial Diseases | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Neoplasms... and other conditionsUnited States, France, Switzerland
-
Promontory Therapeutics Inc.Pfizer; EMD SeronoCompletedNon-Small Cell Lung Cancer (NSCLC)United States, Switzerland
-
University Hospital, Basel, SwitzerlandNot yet recruitingNon-Small Cell Lung CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedNSCLC Non-small Cell Lung CancerSwitzerland
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
ETOP IBCSG Partners FoundationAstraZenecaRecruitingImmunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)Non-small Cell Lung Cancer | Oligometastasis | Stage IVSwitzerland, Netherlands, Spain, Italy
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
European Organisation for Research and Treatment...TerminatedLung CancerFrance, Switzerland, Belgium
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom, Argentina, Japan, Switzerland
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Merck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerUnited States, Israel, Taiwan, Korea, Republic of, Switzerland, Hong Kong
-
PharmaMarCompletedBreast Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Head and Neck Carcinoma | Gynecological Cancer | Non-squamous Cell Lung CancerUnited States, Spain, Switzerland
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
ETOP IBCSG Partners FoundationJanssen PharmaceuticalsRecruitingNon Small Cell Lung CancerSpain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
Swiss Group for Clinical Cancer ResearchCompleted
-
iTeos Belgium SARecruitingMetastatic NSCLC - Non-Small Cell Lung Cancer | Locally Advanced NSCLC - Non-Small Cell Lung CancerUnited Kingdom, Spain, Belgium, France, United States, Switzerland, Italy, Germany, Canada, Czechia, Poland
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
University Hospital, GenevaUnknown
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Spain, Belgium, France, Germany, Hungary, Italy, United Kingdom, Korea, Republic of, Poland, Australia, Switzerland, Singapore, Netherlands, Romania, Czechia, Greece, Ireland, Austria, Russian Federation, Portugal, Hong... and more
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Swiss Group for Clinical Cancer ResearchCompletedNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States, Canada, Germany, Netherlands, Switzerland
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerNetherlands, Finland, Taiwan, Belgium, Canada, Israel, Poland, Spain, Australia, Singapore, Latvia, Thailand, United Kingdom, Germany, Italy, China, Russian Federation, Philippines, Austria, Greece, Hungary, Denmark, France, Ukraine, Li... and more
-
AbbVieActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Belgium, Bulgaria, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland and more
-
UNICANCERCompletedLung CancerFrance, Switzerland, United Kingdom
-
Cellectar Biosciences, Inc.CompletedNon Small Cell Lung CancerUnited States, Israel, Canada, Spain, Russian Federation, Serbia, Italy, Poland, Romania, Switzerland, Ukraine, United Kingdom
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Germany, Spain, Japan, Canada, France, Korea, Republic of, Italy, United Kingdom, China, Taiwan, Hungary, Singapore, Switzerland, Netherlands, Brazil, Mexico, Russian Federation, Puerto Rico, Poland, Hong Kong, Romania and more
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)Russian Federation, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Greece, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Sweden, Swit... and more